Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia

Vascular Medicine

Volumn 5, Issue 4, 2000, Pages 239-242

  Reilly, M P ^a   Weiss, R ^a   Askenase, A ^a   Tuite, C ^a   Soulen, M ^a   Mohler III, E R ^a  

^a PHI Bldg ^*  (United States)

Author keywords

Deep venous thrombosis; Heparin induced thrombocytopenia; Hirudin; Thrombolysis

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN; THROMBIN INHIBITOR; UROKINASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; DEATH; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG ANTAGONISM; FEMORAL ARTERY; HUMAN; LIMB AMPUTATION; LUNG EMBOLISM; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SAFETY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTICOAGULANTS; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PHLEBOGRAPHY; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 0034508723     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/135886300701568531     Document Type: Article

References (23)

1. Heparin-induced thrombocytopenia: A ten-year retrospective
2. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
3. A 14-year study of heparin-induced thrombocytopenia
4. Heparin-induced thrombocytopenia: Towards consensus
5. Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution
6. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study
7. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia
8. Reexposure to heparin of patients with heparin-associated antibodies
9. Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management
10. Recombinant hirudins - An overview of recent developments
11. Treatment of heparin-induced thrombocytopenia
12. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation
13. Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery
14. Heparin-associated thrombocytopenia: The antibody is not heparin specific
15. Persistent heparin induced thrombocytopenia despite therapy with low molecular weight heparin
16. Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216)
17. New treatment options for heparin-induced thrombocytopenia
18. Thrombolysis in heparin-induced thrombocytopenia with thrombosis
19. Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis
20. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes
21. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: Results from the GUSTO-IIb Trial
22. Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction
23. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass - Assessment of the whole blood ecarin clotting time